Drug Trial Radar · NCT02959580
Medical and Surgical Treatment for Idiopathic Granulomatous Mastitis
Last checked: Nov 20, 2026Latest source record: Dec 6, 2018 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
100
Planned (sponsor's estimate)
Start
Jan 1, 2017
Primary completion
Sep 1, 2020
Study completion Sep 2020
Sponsor
- Lead sponsor
- Peking Union Medical College HospitalAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Nov 9, 2016
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- Female only, from 18 years, up to 60 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study evaluates the clinical response rate of topical steroids in the treatment of idiopathic granulomatous mastitis in female adults. Half of the participants will receive topical steroid and the other half will receive local wide surgical excision.
Conditions
- Granulomatous Mastitis
Interventions
Hydrocortisone ButyrateDrug
topical use
extended excisionProcedure
Lesion extended excision with or without a random breast dermo-glandular flap (BDGF).
Primary outcomes
What the sponsor says the trial is designed to measure.
- clinical response rateTime frame: six months
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Department of Breast Surgery,Peking Union Medical College Hospital
Beijing, Beijing Municipality, China · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.